These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 707522)

  • 1. Role of renin and aldosterone suppression in the antihypertensive mechanism of clonidine.
    Niarchos AP; Baer L; Radichevich I
    Am J Med; 1978 Oct; 65(4):614-8. PubMed ID: 707522
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
    Karlberg BE; Nilsson O; Tolagen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):10-20. PubMed ID: 401703
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin and aldosterone suppression in the antihypertensive action of clonidine.
    Weber MA; Case DB; Baer L; Sealey JE; Drayer JI; Lopez-Overjero JA; Laragh JH
    Am J Cardiol; 1976 Nov; 38(6):825-30. PubMed ID: 998518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of clonidine on the renin-angiotensin-aldosterone system in patients with hypertension].
    Casado S; Liaño F; Hernando L
    Rev Clin Esp; 1977 Sep; 146(5):229-32. PubMed ID: 928858
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of clonidine on renin and aldosterone of hypertensive patients.
    Salvetti A; Pedrinelli R; Cavasinni L; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):50-6. PubMed ID: 6989768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clonidine and propranolol, separately and in combination, on blood pressure and plasma renin activity in essential hypertension.
    Weber MA; Drayer JI; Laragh JH
    J Clin Pharmacol; 1978; 18(5-6):233-40. PubMed ID: 641212
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous opioid peptides: do they mediate the acute antihypertensive action of clonidine in humans?
    Levin ER; Sharp B; Weber MA; Drayer JI
    Horm Res; 1986; 23(4):193-9. PubMed ID: 2939015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
    Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.
    Weber MA; Drayer JI; Hubbell FA
    Chest; 1983 Feb; 83(2 Suppl):374-7. PubMed ID: 6822130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.
    Volpe M; Odell G; Kleinert HD; Camargot MJ; Laragh JH; Lewicki JA; Maack T; Vaughan ED; Atlas SA
    J Hypertens Suppl; 1984 Dec; 2(3):S313-5. PubMed ID: 6242558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonidine and the vasodilating beta blocker antihypertensive drug interaction.
    Pettinger WA; Mitchell HC; Güllner HG
    Clin Pharmacol Ther; 1977 Aug; 22(2):164-71. PubMed ID: 18312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of an angiotensin antagonist on blood pressure, renin and aldosterone secretion and its pathogenetic importance].
    Beckerhoff R
    Schweiz Med Wochenschr Suppl; 1978; (7):1-24. PubMed ID: 349683
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.